课题基金 / 基金详情

EPITHELIAL P2X PURINERGIC RECEPTOR CHANNELS

EPITHELIAL P2X PURINERGIC RECEPTOR CHANNELS
上皮 P2X 嘌呤能受体通道
批准号:
6629054
负责人:
Erik Mills Schwiebert
金额:
$20.14万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-02-05 至 2005-01-31

项目摘要

项目成果

Erik Mills Schwiebert的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Cystic fibrosis (CF) airway epithelia have many defects including a loss in chloride (Cl-) and fluid transport, a loss in mucociliary clearance, a loss in apical autocrine and paracrine ATP signaling, and a gain in Na+ transport. Exogenous nucleotide agonists restore extracellular APT signaling and stimulate Cl- and fluid transport in cystic fibrosis (CF) airway epithelia. As such, aerosolized nucleotide agonist therapy has been proposed to treat CF airways. To understand how nucleotide agonists regulate CF and non-CF airway epithelial function, a complete understanding of plasma membrane purinergic receptors is required. Preliminary data from our laboratory reveal that a new class of purinergic receptor, the P2X receptor channels (P2XRs), are expressed by airway epithelia. The cellular and molecular physiology of P2XR expression and function has not been studied in epithelia. P2XRs are ligand-gated channels that bind ATP in an extracellular domain and form intrinsic calcium (Ca2+)- permeable, non-selective cation channels in the plasma membrane. ATP-gated P2XRs may affect epithelial cell function by mediating influx of Ca2+ from extracellular stores or by triggering Ca2+- dependent protein kinase signaling. Therefore, we will test the central hypothesis that: P2X purinergic receptor channels are expressed by airway epithelia and function as ATP-gated Ca2+ influx channels to regulate Cl-, Na+, and fluid transport across airway epithelia. Because little is known about P2XRs in airway epithelia, we anticipate that new and exciting results will be found. Because our preliminary data demonstrate that P2XR expression is similar in CF versus non-CF airway epithelia and beacuase P2XR agonists stimulate Cl- secretion across both CF and non-CF mouse and human airway epithelium in vitro and in vivo, activation of P2XRs may provide a novel approach with which to restore normal Cl-, Na+, and fluid transport across CF airways and improve mucociliary clearance from CF lungs.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
Transient transfection of polarized epithelial monolayers with CFTR and reporter genes using efficacious lipids.
使用有效脂质瞬时转染带有 CFTR 和报告基因的极化上皮单层。
DOI: 10.1152/ajpcell.00435.2002
发表时间: 2003
期刊: American journal of physiology. Cell physiology
影响因子: --
作者: [Tucker,TorryA, Varga,Karoly, Bebok,Zsuzsa, Zsembery,Akos, McCarty,NaelA, Collawn,JamesF, Schwiebert,ErikM, Schwiebert,LisaM]
通讯作者: Schwiebert,LisaM
DOI: 10.1152/ajpcell.00491.2004
发表时间: 2005-08
期刊: American journal of physiology. Cell physiology
影响因子: --
作者: [L. Liang;Á. Zsembery;E. Schwiebert]
通讯作者: L. Liang;Á. Zsembery;E. Schwiebert
DOI: 10.1152/ajpcell.00532.2004
发表时间: 2005
期刊: American journal of physiology. Cell physiology
影响因子: --
作者: [Liang,Lihua, Schwiebert,ErikM]
通讯作者: Schwiebert,ErikM
DOI: 10.1152/ajpcell.2000.279.2.c281
发表时间: 2000-08
期刊: American journal of physiology. Cell physiology
影响因子: --
作者: [E. Schwiebert]
通讯作者: E. Schwiebert
Genotyped and Single Cyst-derived Human ADPKD Cell Platforms for Industry and Academia
  • 批准号:
    9139596
  • 项目类别:
  • 资助金额:
    $36.62万
  • 财政年份:
    2016
  • 负责人:
    Erik Mills Schwiebert
  • 依托单位:
DBM Anti-Proliferative Lead Small Molecules for Polycystic Kidney Disease
  • 批准号:
    8454042
  • 项目类别:
  • 资助金额:
    $43.66万
  • 财政年份:
    2013
  • 负责人:
    Erik Mills Schwiebert
  • 依托单位:
DBM Anti-Proliferative Lead Small Molecules for Polycystic Kidney Disease
  • 批准号:
    8803107
  • 项目类别:
  • 资助金额:
    $50.34万
  • 财政年份:
    2013
  • 负责人:
    Erik Mills Schwiebert
  • 依托单位:
DBM Anti-Proliferative Lead Small Molecules for Polycystic Kidney Disease
  • 批准号:
    8892174
  • 项目类别:
  • 资助金额:
    $63.17万
  • 财政年份:
    2013
  • 负责人:
    Erik Mills Schwiebert
  • 依托单位:
海外基金